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FICZ: A Messenger of Light in
Human Skin
Deeba N. Syed1 and Hasan Mukhtar1
Photosensitization, subsequent to photon absorption by chromophores present
in the human skin, appears to be a key mechanism of UV-induced oxidative
stress. The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ), an
aryl hydrocarbon receptor ligand, has been found to be a potent UVA
photosensitizer, effective at nanomolar concentrations. A novel addition to the
family of endogenous photosensitizers, the precise mechanism(s) through which
it mediates oxidative stress in UVA exposed skin and its response to the UVB
spectrum of the solar UV ﬂux remains unexplored. Further studies related to its
functionality in the human skin, its utility as a tool against UV-induced adverse
effects, and its role in inﬂammatory skin diseases will have the potential to open
up new avenues in the realms of human skin photobiology.
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A study published in this issue of the
journal sheds light on the previously
unexplored photosensitizing efﬁcacy of
6-formylindolo[3,2-b]carbazole (FICZ)
in epidermal keratinocytes. Greater
than 95% of the UV energy derived
from solar radiation incident on the
human skin comprises the deeply pene-
trating longer wavelength UVA (320–
400 nm), whereas the UVB (290–
320 nm) content on the skin varies
between 2 and 5% (Wondrak et al.,
2006). Understandably, there exists a
positive correlation between wave-
lengths and skin photon pene-
tration so that 100-fold higher photon
energy is delivered to the lower epider-
mis and upper dermis in the UVA as
compared with the UVB region
(Wondrak et al., 2006). The sub-
sequent generation of reactive oxygen
species (ROS), responsible for UV
photodamage, occurs through various
mechanisms including UV-enhanced
electron leakage from the mitochondrial
respiratory chain and remodeling of
cholesterol-rich plasma membrane rafts
of keratinocytes (Gniadecki et al.,
2002). Nonetheless, photosensitization
by endogenous non-DNA chromo-
phores present in the human skin
subsequent to photon absorption
appears to be an important mechanism
of UV-induced ROS production
(Wondrak et al., 2006). The sensitizer
chromophores after initial photon
absorption either revert to the ground
state by energy dissipation or form
highly reactive bi-radical triplet states.
The long lived triplet state of the
sensitizer serves as a key photoexcited
intermediate that induces skin photo-
damage through direct interaction with
substrate molecules such as DNA bases
(type I reaction) or activation of mole-
cular oxygen via electron or energy
transfer reactions (type II reaction)
resulting in ROS generation (Castano
et al., 2004). The superoxide radical
anions derived from these type I or II
photosensitization reactions result in
the formation of hydrogen peroxide
through spontaneous dismutation
(Castano et al., 2004). UVA has been
shown to induce the formation of cyclo-
butane pyrimidine dimers subsequent to
triplet energy transfer from excited
photosensitizers to pyrimidine bases.
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The dynamics of cellular DNA damage
by UVA is dependent on various factors
such as the location of photosensitizers
in the cell, their chemical properties, and
the concentration of oxygen (Hiraku
et al., 2007). Pouget et al. (2000) have
reported that singlet oxygen is the main
reactive species in the formation of UVA-
induced DNA damage within cells, but
hydroxyl radicals and Type I photosensi-
tization may be involved.
Accordingly, a variety of cellular com-
pounds have been identiﬁed as potent
endogenous photosensitizers. These
include porphyrins (subclassifed as uro-
porphyrins, coproporphyrins, and proto-
porphyrin IX), bilirubin, melanin and its
precursors, ﬂavins, pterins and so on.
Conversely, certain drugs may act as
exogenous photosensitizers and contri-
bute to the development of human skin
cancers. The PUVA therapy where Pso-
larens, in combination with UVA irradia-
tion, is used for treatment of psoriasis
reportedly increases the incidence of skin
cancer (Archier et al., 2012). Nalidixic
acid and ﬂuoroquinolone antibacterials,
used for the treatment of infectious
diseases, cause skin tumors in animals
exposed to UVA through induction of
DNA damage (Klecak et al., 1997).
Some naturally occurring amino acids
such as histidine, tryptophan, tyrosine,
and phenylalanine are known to absorb
UV directly, resulting in electronically
excited states and photoionization reac-
tions. Tryptophan, present both in a free
form and as a constituent of proteins in
biological systems, a precursor of many
signaling molecules including serotonin
and melatonin, is an essential endogen-
ous chromophore linked to the cellular
photooxidative processes (Wei et al.,
1999). The ligand-dependent aryl hydro-
carbon receptor (AhR), a transcription
factor, expressed ubiquitously in mam-
malian cells has been proposed to be a
light sensor in melanocytes and keratino-
cytes, as it is transcriptionally activated by
both visible and UV light (Wei et al.,
1999). Numerous compounds, possessing
a wide range of chemical structures have
been recognized as agonists for AhR.
Interestingly, a number of AhR ligands
such as trypthantrin, indigo, malassezin,
indirubin, and indolocarbazoles are
derivatives of tryptophan (Bergander
et al., 2004). Several feedback processes
tightly regulate AhR signaling in the cell.
A low steady-state level of AhR ligands is
maintained through activation of phase I
and phase II, enzymes responsible for the
metabolic degradation of these endogen-
ous compounds (Bergander et al., 2004).
In turn, the ligands in complex with AhR
activate the transcription of genes
encoding for metabolic enzymes
including the cytochrome P450 (CYP)
family members CYP1A1, 1A2 and 1B1,
NADPH quinone oxidoreductase, gluta-
thione transferase and so on, thereby
contributing to the regulation of AhR-
dependent gene expression (Bergander
et al., 2004).
The tryptophan photoproduct FICZ was
identiﬁed as an AhR ligand following
studies when it was noted that light
exposed cell-culture medium induced
AhR-mediated activation of CYP1A1,
dependent on tryptophan but indepen-
dent of riboﬂavin and other components
in the medium (Oberg et al., 2005).
Moreover, it was observed that to attain
the FICZ concentration needed to induce
CYP1A1, a very small percentage
(~0.001%) of the intracellular tryptophan
is required to be converted to FICZ (Ma,
2011). Studies conﬁrmed that FICZ binds
to AhR with a 4–7-fold higher afﬁnity
compared with the archetypal AhR
agonist 2,3,7,8-tetrachlorodibenzo-p-
dioxin. FICZ tightly bound to AHR is an
ideal substrate for CYPs and participates
in an autoregulatory loop that maintains
its own steady-state concentration at a
low level. FICZ, metabolized by AhR-
mediated induction of CYP1A1, CYP1A2,
and CYP1B1 enzymes, yields a number of
hydroxylated and conjugated derivatives,
which retain the formyl group in its
original or oxidized form (Bergander
et al., 2004). It has been demonstrated
that various chemical compounds can
interfere with the metabolism of FICZ,
thereby hindering the regulatory control
by CYPs and other AhR-regulated pro-
teins. In vitro studies show that if its
metabolic clearance is compromised,
minuscule femtomolar background levels
of FICZ in cell-culture medium are sufﬁ-
cient to enhance CYP1A1 mRNA and
enzyme activity (Wincent et al., 2012).
Thus, the metabolism of FICZ ﬁts into a
proposed autoregulatory model where
AhR signaling activated by its various
ligands is regulated by parallel induction
of metabolic enzymes (Bergander et al.,
2004).
The physiological functions of FICZ
had until now escaped detection. Recent
studies indicated the involvement of FICZ
in several biological roles, including
regulation of the circadian rhythm, home-
ostasis associated with pro- and anti-
inﬂammatory processes, and mainte-
nance of genomic stability (Ma, 2011).
Prompted by the observations that UVB
irradiation induced the formation of
tryptophan photoproducts that led to
activation of AhR and induction of
CYPs, Fritsche et al. (2007) proceeded to
demonstrate that FICZ generated in UVB
exposed keratinocytes starts a cascade of
signaling events via activation of the cyto-
plasmatic AhR with EGFR internalization,
activation of ERK1/2, and induction of
cyclooxygenase-2, thereby contributing
to the UV stress response.
“The data generated thus
far indicate that the
enigmatic ligand for the
AhR, FICZ is the most
potent endogenous
UVA photosensitizer
identiﬁed till date
(Park et al., 2015). The
next step would be to
explore the therapeutic
efﬁcacy of the
compound in model
systems that closely
simulate human skin and
allow qualitative and
quantitative control of
the photosensitizer
and then further extend
these studies to human
patients.”
Follow-up studies by Park et al., (2015)
examined the photodynamic potency of
FICZ in the UVA exposed skin. Through a
series of well-designed in vitro experi-
ments, the authors uncovered the
mechanism through which the high-
afﬁnity AhR agonist acts as a nanomolar
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photosensitizer and potentiates oxidative
stress induced by UVA, independent of
AhR ligand activity. Park et al. (2015)
demonstrated that photodynamic activity
by FICZ could be elicited by either UVA
or blue light photoexcitation, a ﬁnding
consistent with its UV/VIS absorption
characteristic. Moreover, the authors pro-
vided evidence of the extraordinary
photodynamic efﬁcacy of FICZ that sur-
passed that of known endogenous
photosensitizers including protopor-
phyrin IX and riboﬂavin (Park et al.,
2015). They further showed that the
combinatorial treatment of FICZ and
UVA resulted in pronounced phototoxi-
city inducing keratinocyte cell death in
epidermal tissue reconstructs and murine
skin. The photosensitization caused by
FICZ was associated with induction of
intracellular oxidative stress and oxidative
DNA lesions (Park et al., 2015).
Photodynamic therapy, widely emplo-
yed for the treatment of cutaneous patho-
logies including cancer, uses a combina-
tion of light and a photosensitizing drug
to cause targeted damage to the tissue
through the generation of ROS. ROS, in
turn, contingent upon its amount and
localization in the target tissue, can
modulate cellular functions or incur cell
death by apoptosis or necrosis (Nayak,
2005). An ideal photosensitizer is an
agent with negligible toxicity without
irradiation, has potent photocytotoxicity,
is selective in its target, absorbs long
wavelengths, can be administered with
ease through various routes, and is rapidly
removed from the body. Many of the
photosensitizers currently used in clinical
practice belong to the porphyrin family
and multiple generations of these com-
pounds have been developed (Mahmoud
et al., 2008). The data generated thus far
indicate that the enigmatic AhR ligand,
FICZ, is the most potent endogenous UVA
photosensitizer identiﬁed till date (Park
et al., 2015). The next step would be to
explore the therapeutic efﬁcacy of the
compound in model systems that closely
simulate human skin and allow quali-
tative and quantitative control of the
photosensitizer and then further extend
these studies to human patients.
The AhR is being explored for its
effect on inﬂammatory skin disease.
Interestingly, ligands that activate AhR
signaling have been shown to reduce
inﬂammation in the lesional skin of
psoriasis patients, whereas antagonists
of AhR tend to increase inﬂammation.
In this context, AhR signaling via
its ligand FICZ reportedly attenuated
the inﬂammatory response in the
imiquimod-induced murine model of
skin inﬂammation, whereas AhR-
deﬁcient animals exhibited an increase
in the severity of the disease, compared
with the AhR-positive controls (Di
Meglio et al., 2014). In vitro studies
showed that UV exposure sensitized
human keratinocytes to polycyclic aro-
matic hydrocarbon (PAH)-induced
DNA adduct formation through induc-
tion of CYPs in human keratinocytes, an
effect that was mimicked by FICZ
treatment (Afaq et al., 2009; Nair
et al., 2009). The AhR/FICZ signaling
thus represents a potential target for
skin carcinogenesis, and it is reasonable
to assume that suppressing UV/FICZ-
mediated induction of CYP1A1
and CYP1B1, carcinogen activating
enzymes, should reduce the forma-
tion of DNA adducts and inhibit
carcinogenesis. Conversely, studies
in CYP1A1 and CYP1B1 knockout
mice show a protective effect of these
enzymes against benzo(a)pyrene
toxicity as their absence leads to an
increase in DNA adducts (Uno et al.,
2001). This effect was also observed in
some models of PAH-induced carcino-
genesis (Anderson et al., 1989). Given
the inconsistency of the data, the role of
FICZ in skin carcinogenesis remains to
be elucidated.
In addition to its solar UV-driven
origin, FICZ also occurs as a common
metabolite of Malassezia yeast com-
mensals and has been implicated in
the pathogenesis of cutaneous diseases
including seborrheic dermatitis. Analy-
tical and biological assays have
revealed the presence of a pool of FICZ
and other tryptophan metabolites in the
human skin (Magiatis et al., 2013). The
existence of FICZ in the patho-
physiological background of inﬂamma-
tory skin lesion raises some interesting
questions. In the case of deregulated
molecular pathways in the pathological
or aged skin, how does the functionality
of FICZ, a UVA photosensitizer, differ?
What would be the consequence of
FICZ generation, upon chronic UV
exposure in the presence of persistent
inﬂammation and overstimulated skin
metabolism? Remarkably, the response
of FICZ to UVA radiation is independent
of its role as a potential signaling
molecule for keratinocytes, thought to
mount adaptive responses against UVB,
in an AhR-dependent manner. The
study by Park et al. (2015) establishing
the photosensitizing efﬁcacy of FICZ
in the human skin, independent of
AhR, indicates two parallel pathways
operating in the UV exposed skin,
mediated by different UV wavelengths
(Figure 1). What if any would be
the balance that the UV exposed skin
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Figure 1. Schematic representation of 6-formylindolo[3,2-b]carbazole (FICZ)-mediated effects in
UV exposed human skin. AhR, aryl hydrocarbon receptor; CYP, cytochrome P450.
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needs to achieve to exploit the anti-
inﬂammatory effect of FICZ, observed in
certain experimental models? Many indi-
viduals with precancerous lesions con-
tinue to expose themselves to the sun. It
remains to be seen how this photosensi-
tizer contributes to skin carcinogenesis
in such cases. Furthermore, it is still
uncertain how much UV exposure is
required for its beneﬁcial or detrimental
effects in a human setting. As the bulk
of the studies performed so far have
used single wavelength, future studies
employing a combination of UVA and
UVB simulating the solar UV spectrum
will provide better insight into the
mechanism(s) involved.
In summary, this study contributes to
our understanding of the role of endo-
genous photosensitizers in the human
skin. Rigorous characterization of the
novel chromophore FICZ in response
to different wavelengths of UV spec-
trum and the molecular mechanisms
involved in photooxidative stress
will reveal innovative opportunities for
its exploitation in cutaneous patho-
logies.
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Hairy Math: Addition of Wnt-3a to
Multiply Bulge Cells
M. Zulﬁquer Hossain1 and Luis A. Garza1
Canonical Wnt signals are important for activation of epithelial skin stem cells,
but the role of individual Wnt ligands remains uncertain. Ouji et al. demonstrate
a key role for Wnt-3a in partial maintenance and long-term expansion of
epithelial skin stem cells in vitro. They also report a method for expanding these
cells in vitro without feeder cells.
Journal of Investigative Dermatology (2015) 135, 1481–1483. doi:10.1038/jid.2014.545
The role of canonical Wnt-β-catenin
signaling in hair follicle and epithelial
stem cell biology has intrigued
investigators for years. Numerous stu-
dies have implicated this signaling
cascade in different aspects of hair
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